Skip to main content
. 2014 May 21;105(7):875–882. doi: 10.1111/cas.12426

Figure 1.

Figure 1

Glabridin (GLA) inhibits the migratory capacity of human breast cancer cells. (a) Effects of GLA on the viability of breast cancer cells. MDA-MB-231 and BT-549 breast cancer cells were exposed to 0.0, 5.0, 10.0 or 20.0 μM GLA for 4 days. Their viability was measured by use of a Cell Counting Kit-8 assay. The relative folds of cell viability were determined by comparing growth of cells not exposed to GLA. (b) Cells were exposed to 0.0, 5.0, 10.0 or 20.0 μM GLA for 4 days. After the cells were wounded, they were exposed to the same concentrations of GLA for another 24 h. GLA attenuated the migratory capacity of MDA-MB-231 (top) and BT-549 (bottom) cells, as determined by scratch wound-healing assays. (c) Relative levels of cell migration.